Analysed AB SCIENCE SA (ABSCF:OTCMKTS) News Sources
Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
19-02-2026
yahoo.com
AB Science announces the identification of a plasma biomarker that indicates the activity of masitinib in treating ALS
24-02-2026
yahoo.com
AB Science: New publication on medrxiv demonstrating substantial survival benefits and preserved quality of life with masitinib in ALS patients
20-04-2026
yahoo.com
AB Science announces a final agreement on the renegotiation of the repayment terms of its loans with all of its financial creditors
27-04-2026
yahoo.com
AB Science announces the successful completion of a EUR 3.2 million private placement
29-04-2026
yahoo.com
AB Science reports its revenues for the year 2025 and provides an update on its activities
13-05-2026
yahoo.com
Masitinib Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
15-05-2026
yahoo.com
AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share
25-05-2026
yahoo.com
What is the current price of AB SCIENCE SA (ABSCF:OTCMKTS)?
The current price of AB SCIENCE SA (ABSCF:OTCMKTS) is $1.12.
AB SCIENCE SA (ABSCF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of AB SCIENCE SA (ABSCF:OTCMKTS) since the previous trading day is $0.
AB SCIENCE SA (ABSCF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of AB SCIENCE SA (ABSCF:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for AB SCIENCE SA (ABSCF:OTCMKTS)?
The most recent average sentiment score for AB SCIENCE SA (ABSCF:OTCMKTS) is 58 out of 100.
What is the most recent average sentiment for AB SCIENCE SA (ABSCF:OTCMKTS)?
The most recent sentiment for AB SCIENCE SA (ABSCF:OTCMKTS) is .
SEC-8K** Filing Available For AB SCIENCE SA (ABSCF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.